Walleye Trading’s Neurogene NGNE Stock Holding History

Walleye Trading’s Portfolio NGNE Stock Details NGNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-40	Closed	-$6K	–	5336
2015 Q2	$6K	Buy	+40	New	+$6.09K	﹤0.01%	4452

Other funds holding NGNE

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

VAM

Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Walleye Trading's NGNE Position: Q3 2015 in Review

Walleye Trading sold out of Neurogene (NGNE) in Q3 2015, closing a stake of 40 shares — an estimated $6K sold.

Walleye Trading first reported a position in NGNE in Q2 2015 and held it in 1 quarter. The position peaked at $6K in Q2 2015. 33 funds tracked by Wall St. Rank hold NGNE as of Q3 2015.

Walleye Trading reported no remaining Neurogene position as of Q3 2015 after selling out during the quarter.
Walleye Trading sold 40 Neurogene shares in Q3 2015, an estimated $6K.
Walleye Trading first reported a position in Neurogene in Q2 2015 and held it in 1 quarter.
Walleye Trading's Neurogene position peaked at $6K in Q2 2015.
33 funds tracked by Wall St. Rank held Neurogene as of Q3 2015.

Based on Walleye Trading's 13F filing for Q3 2015, filed 16 Nov 2015.